Article Text

Download PDFPDF

Journal club
ERK3 in lung cancer cell invasion
  1. Arthee Yogendran
  1. Correspondence to Dr Arthee Yogendran, FY2, Medway NHS Foundation Trust, Department of Thoracic Medicine, Windmill Road, Gillingham ME7 5NY, UK; artheey{at}

Statistics from

ERK3, an atypical mitogen-activated protein kinase, was first identified 20 years ago, and its role in cancer development is yet to be fully elucidated. Steroid receptor coactivator 3 (SRC-3) has been well described in a number of different cancers, including lung cancer, as a nuclear receptor coactivator of PEA3-regulated MMP expression to promote cancer cell invasion.

The authors use immunoprecipitation analysis in H1299 lung cancer cells to identify the oncogene SRC-3 as a substrate of the ERK3-signalling cascade for phosphorylation at serine 857(S857). Additionally, overexpression of ERK3 and SRC-3 was shown to enhance MMP2 activity, while mutation of S857, as well as knockdown of ERK3 and SRC-3, inhibited MMP2 expression. Phosphorylation of S857 was an essential step in encouraging interaction of SRC-3 and PEA3 and occupancy at the MMP2 promoter.

A 7.4-fold increased expression of ERK3 mRNA was noted in squamous cell lung carcinoma compared with normal lung tissue, which was confirmed with immunohistochemistry. Further experiments using mice models with ERK3/SRC-3 knockdown indicated eliminated invasion potential of H1299 cells, with no lung cancer cell colonisation seen after 5 weeks.

This study works towards increasing understanding of the ERK3 signalling pathway: phosphorylation of SRC-3 at S857 and MMP expression via PEA coactivation. The clinical implications of upregulation of ERK3 in squamous cell lung cancer, and its role in promoting cell invasion, may provide a new potential therapeutic target for this cancer sub-group.

▸ Long W, Foulds CE, Qin J, et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest 2012;122:1869–80.


  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.